Dose dependent neuroprotection of the noble gas argon after cardiac arrest in rats is not mediated by KATP-Channel opening

Resuscitation

Volumn 85, Issue 6, 2014, Pages 826-832

  Brücken, Anne ^a   Kurnaz, Pinar ^a   Bleilevens, Christian ^a   Derwall, Matthias ^a   Weis, Joachim ^a   Nolte, Kay ^a   Rossaint, Rolf ^a   Fries, Michael ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Argon; Brain; Cardiopulmonary resuscitation; Hypoxia ischaemia; Neuroprotective agents; Reperfusion injury

Indexed keywords

5 HYDROXYDECANOIC ACID; ADENOSINE TRIPHOSPHATE; ARGON; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; NEUROPROTECTIVE AGENT;

AIR CONDITIONING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DENTATE HILUS; HEART ARREST; HIPPOCAMPAL CA3 REGION; HISTOPATHOLOGY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEOCORTEX; NEUROLOGIC DISEASE; NEUROLOGICAL DEFICIT SCORE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; RESUSCITATION; SURGICAL TECHNIQUE; ANIMAL; BRAIN DISEASES; COMPLICATION; DISEASE MODEL; DOSE RESPONSE; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; ARGON; BRAIN DISEASES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART ARREST; KATP CHANNELS; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84901269918     PISSN: 03009572     EISSN: 18731570     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2014.02.014     Document Type: Article

References (32)

1. Coburn M., Maze M., Franks N.P. The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit Care Med 2008, 36:588-595.
2. Dingley J., Tooley J., Porter H., Thoresen M. Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke 2006, 37:501-506.
3. Luo Y., Ma D., Ieong E., et al. Xenon and sevoflurane protect against brain injury in a neonatal asphyxia model. Anesthesiology 2008, 109:782-789.
4. Ma D., Wilhelm S., Maze M., Franks N.P. Neuroprotective and neurotoxic properties of the 'inert' gas, xenon. Br J Anaesth 2002, 89:739-746.
5. Schmidt M., Marx T., Gloggl E., Reinelt H., Schirmer U. Xenon attenuates cerebral damage after ischemia in pigs. Anesthesiology 2005, 102:929-936.
6. Fries M., Nolte K.W., Coburn M., et al. Xenon reduces neurohistopathological damage and improves the early neurological deficit after cardiac arrest in pigs. Crit Care Med 2008, 36:2420-2426.
7. Fries M., Brücken A., Cizen A., et al. Combining xenon and mild therapeutic hypothermia preserves neurological function after prolonged cardiac arrest in pigs. Crit Care Med 2012, 40:1297-1303.
8. Derwall M., Coburn M., Rex S., et al. Xenon: recent developments and future perspectives. Minerva Anestesiol 2009, 75:37-45.
9. Yarin Y.M., Amarjargal N., Fuchs J., et al. Argon protects hypoxia-, cisplatin- and gentamycin-exposed hair cells in the newborn rat's organ of Corti. Hear Res 2005, 201:1-9.
10. Loetscher P.D., Rossaint J., Rossaint R., et al. Argon: neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Crit Care 2009, 13:R206.
11. Jawad N., Rizvi M., Gu J., et al. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett 2009, 460:232-236.
12. Ryang Y.M., Fahlenkamp A.V., Rossaint R., et al. Neuroprotective effects of argon in an in vivo model of transient middle cerebral artery occlusion in rats. Crit Care Med 2012, 39:1448-1453.
13. Brücken A., Cizen A., Fera C., et al. Argon reduces neurohistopathological damage and preserves functional recovery after cardiac arrest in rats. Br J Anaesth 2013, 110:i106-i112.
14. Harris K., Armstrong S.P., Campos-Pires R., Kiru L., Franks N.P., Dickinson R. Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the n-methyl-d-aspartate receptor glycine site. Anesthesiology 2013, 119:1137-1148.
15. David H.N., Haelewyn B., Degoulet M., Colomb D.G., Risso J.J., Abraini J.H. Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult. PLoS ONE 2012, 7:e30934.
16. Bantel C., Maze M., Trapp S. Neuronal preconditioning by inhalational anesthetics: evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology 2009, 110:986-995.
17. Bantel C., Maze M., Trapp S. Noble gas xenon is a novel adenosine triphosphate-sensitive potassium channel opener. Anesthesiology 2010, 112:623-630.
18. Idris A.H., Becker L.B., Ornato J.P., et al. Utstein-style guidelines for uniform reporting of laboratory CPR research. A statement for healthcare professionals from a Task Force of the American Heart Association, the American College of Emergency Physicians, the American College of Cardiology, the European Resuscitation Council, the Heart and Stroke Foundation of Canada, the Institute of Critical Care Medicine, the Safar Center for Resuscitation Research, and the Society for Academic Emergency Medicine. Resuscitation 1996, 33:69-84.
19. Stark R.A., Nahrwold M.L., Cohen P.J. Blind oral tracheal intubation of rats. J Appl Physiol 1981, 51:1355-1356.
20. Neumar R.W., Bircher N.G., Sim K.M., et al. Epinephrine and sodium bicarbonate during CPR following asphyxial cardiac arrest in rats. Resuscitation 1995, 29:249-263.
21. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003, 463:3-33.
22. Zhuang L.Y.T., Zhao H., Fidalgo A., et al. The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats. Crit Care Med 2012, 40:1724-1730.
23. Franks N.P., Dickinson R., de Sousa S.L., Hall A.C., Lieb W.R. How does xenon produce anaesthesia?. Nature 1998, 396:324.
24. Sanders R.D., Franks N.P., Maze M. Xenon: no stranger to anaesthesia. Br J Anaesth 2003, 91:709-717.
25. Gruss M., Bushell T.J., Bright D.P., Lieb W.R., Mathie A., Franks N.P. Two-pore-domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol 2004, 65:443-452.
26. Ma D., Hossain M., Chow A., et al. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 2005, 58:182-193.
27. Hobbs C., Thoresen M., Tucker A., Aquilina K., Chakkarapani E., Dingley J. Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia/ischemia. Stroke 2008, 39:1307-1313.
28. Chakkarapani E., Dingley J., Liu X., et al. Xenon enhances hypothermic neuroprotection in asphyxiated newborn pigs. Ann Neurol 2010, 68:330-341.
29. Fahlenkamp A.V., Rossaint R., Haase H., et al. The noble gas argon modifies extracellular signal-regulated kinase 1/2 signaling in neurons and glial cells. Eur J Pharmacol 2012, 674:104-111.
30. Laver S., Farrow C., Turner D., Nolan J. Mode of death after admission to an intensive care unit following cardiac arrest. Intensive Care Med 2004, 30:2126-2128.
31. Zarch A.V., Toroudi H.P., Soleimani M., Bakhtiarian A., Katebi M., Djahanguiri B. Neuroprotective effects of diazoxide and its antagonism by glibenclamide in pyramidal neurons of rat hippocampus subjected to ischemia-reperfusion-induced injury. Int J Neurosci 2009, 119:1346-1361.
32. Robin E., Simerabet M., Hassoun S.M., et al. Postconditioning in focal cerebral ischemia: role of the mitochondrial ATP-dependent potassium channel. Brain Res 2011, 1375:137-146.